Opioid Drugs Market, By Drug Class, By Application, By Route of Administration, By Distribution Channel, By Geography

Description

Opioid Drugs Market is estimated to be valued at USD 49.70 Bn in 2026 and is expected to reach USD 63.23 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 49.70 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.50%	2033 Value Projection:	USD 63.23 Bn

Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs 'morphine' was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.

Market Dynamics

Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure-activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.

Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grunenthal acquired the U.S.-based pharmaceutical company 'Averitas Pharma' in order to expand its presence in the U.S.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global opioids market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
Alkaloids
Semisynthetic Opioids
Synthetic Opioids
Application Insights (Revenue, USD Bn, 2026 - 2033)
Analgesia
Cough Suppression
Diarrhea Suppression
Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
Oral
Topical
Parenteral
Others
Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Key Players Insights
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson
Endo International plc
Lupin Limited
Cadila Healthcare Limited
Purdue Pharma L.P.
AbbVie Inc.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Rhodes Pharmaceuticals L.P.
Sun Pharmaceutical Industries Limited
Nesher Pharmaceuticals (USA) LLC
Amneal Pharmaceuticals LLC
Trevena Inc.
Aurobindo Pharma Limited

Product Code: CMI1017

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
Reimbursement Scenario
PEST Analysis
PORTER'S Analysis

4. Global Opioid Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
  - Morphine
  - codeine
Semisynthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
  - Oxycodone
  - Hydrocodone
  - Hydromorphone
Synthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
  - Fentanyl
  - Alfentanil

5. Global Opioid Drugs Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends

6. Global Opioid Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Others (Intramuscular, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends

7. Global Opioid Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Opioid Drugs Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Endo International plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lupin Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cadila Healthcare Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Purdue Pharma L.P.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AbbVie Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Kabi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mallinckrodt Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Rhodes Pharmaceuticals L.P.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sun Pharmaceutical Industries Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Nesher Pharmaceuticals (USA) LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Amneal Pharmaceuticals LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Trevena Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aurobindo Pharma Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

10. Section

References
Research Methodology
About us and Sales Contact